Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3 reference.
    Difference
    0.0%
    Check dated 2026-03-25T07:17:59.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3, indicating a minor version update to the page.
    Difference
    0.0%
    Check dated 2026-03-10T15:57:35.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 in the Study Documents section; the rest of the page content and study information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T04:16:56.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new site revision tag, Revision: v3.4.1, appears, with the previous tag Revision: v3.4.0 removed, and a government funding status notice is displayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-10T01:16:09.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    A top banner states that there is a lapse in government funding and information may not be up to date, and notes that the NIH Clinical Center is open with links to status updates.
    Difference
    0.3%
    Check dated 2026-02-02T21:36:05.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The changes are cosmetic UI updates: a glossary toggle is displayed, capitalization tweaks in QC-related labels, and a new revision version (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-26T20:45:34.000Z thumbnail image

Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.